Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2013 1
2019 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma.
Nozawa T, Okada M, Natsumeda M, Eda T, Abe H, Tsukamoto Y, Okamoto K, Oishi M, Takahashi H, Fujii Y, Kakita A. Nozawa T, et al. Among authors: eda t. Neurol Med Chir (Tokyo). 2019 Mar 15;59(3):89-97. doi: 10.2176/nmc.oa.2018-0078. Epub 2019 Feb 21. Neurol Med Chir (Tokyo). 2019. PMID: 30787232 Free PMC article.
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
Ando K, Natsumeda M, Kawamura M, Shirakawa K, Okada M, Tsukamoto Y, Eda T, Watanabe J, Saito S, Takahashi H, Kakita A, Oishi M, Fujii Y. Ando K, et al. Among authors: eda t. Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21. Thromb Res. 2023. PMID: 36706720
Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative cases.
Tsukamoto Y, Natsumeda M, Takahashi H, Ueno A, Sakai K, Shida K, Seto H, Saito T, Shibuma S, Nakayama Y, Tanaka Y, Nakano T, Ohta A, Maruyama K, Okada M, Eda T, Seki Y, Yoneoka Y, Shimizu H, Okamoto K, Kakita A, Oishi M. Tsukamoto Y, et al. Among authors: eda t. J Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23361. doi: 10.3171/CASE23361. Print 2023 Oct 16. J Neurosurg Case Lessons. 2023. PMID: 37870755 Free PMC article.
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate-Case Report.
Mouri Y, Natsumeda M, Okubo N, Sato T, Saito T, Shibuya K, Yamada S, On J, Tsukamoto Y, Okada M, Oishi M, Eda T, Murai J, Shimizu H, Kakita A, Fujii Y. Mouri Y, et al. Among authors: eda t. J Clin Med. 2022 Sep 22;11(19):5548. doi: 10.3390/jcm11195548. J Clin Med. 2022. PMID: 36233415 Free PMC article.
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J, Natsumeda M, Takahashi H, Koyama A, Shibuma S, Shibata N, Watanabe J, Saito S, Kanemaru Y, Tsukamoto Y, Okada M, Ogura R, Eda T, Tada M, Shimizu H, Adachi JI, Mishima K, Nishikawa R, Kakita A, Oishi M. On J, et al. Among authors: eda t. J Neurooncol. 2024 Jan;166(2):273-282. doi: 10.1007/s11060-023-04555-5. Epub 2024 Jan 16. J Neurooncol. 2024. PMID: 38227143
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y. Kanemaru Y, et al. Among authors: eda t. Acta Neuropathol Commun. 2019 Jul 25;7(1):119. doi: 10.1186/s40478-019-0774-7. Acta Neuropathol Commun. 2019. PMID: 31345255 Free PMC article.